I believe IPIX has already attained the very favorable results many of us were hoping to hear from the lab testing, the increased visibility across the medical spectrum, and soon-to- be visibility across the world public spectrum.

Now we have set much loftier goals for the CV program and Brilacidin to date looks like the drug to beat as it seems exactly what the world was looking for in a drug to treat the symptoms, end the death threat to many, and likely allow world economies to get back to work.

We knew we had a gem, nice to see it getting a chance to strut it's stuff.

Pricing today surprising but I am sure we will all be quite pleased as the news gets out to the general public and they come to realize how far beyond the other "pretender" solutions to CV Brilacidin truly is.

Great day.